This second edition of this book expands further on the first edition, which explored the relationship between the human immune system and the skeletal structure. In the past, scientists involved in immune and bone-cell investigations have rarely interacted in a significant way, as these disciplines have developed independently and, for the most part, remain separate. This book brings together ideas of international scientists from both fields in pursuit of new collaborations. This may facilitate greater understanding of the relationship between these fields.

This book includes these topics: A Key Regulator of Postnatal Skeletal Remodeling; Ectodomain Shedding of Receptor Activator of NF-KB Ligand; The Negative Role Of Ids In Osteoclastogenesis; Functional Genetic and Genomic Analysis of Modeled Arthritis; Dexamethsone Suppresses Bone Formation via the Osteoclast; Immunologic Regulation Of Bone Development; Pth Regulates The Hematopoietic Stem Cell Niche In Bone; Regulation Of Hematopoietic Stem Cells In The Osteoblastic Niche; The Chemokine Cxcl12; and Regulation Of Hsc; and Lymphocyte Development In The Bone Marrow Niche. It also includes these topics: Osteoclast Precursor Cells; Interaction with estrogen receptors as treatment of arthritis and osteoporosis; Novel Signaling Pathways And Therapeutic Targets In Osteoclasts; The Enigmatic Function of TREM-2 in Osteoclastogenesis; Role of cell-matrix interactions in osteoclast differentiation; Positive and negative roles of IL-6, STAT3 and SOCS3 in inflammatory arthritis; Control of Osteoclast activity and bone loss by IKK subunits: new targets for therapy; Targeting Osteoporosis And Rheumatoid Arthritis By Active Vaccination Against Rankl; and RANKL Inhibition: From Mice to Men (and Women).

It has only recently been appreciated that the immune and skeletal systems have major interactions. It is now well documented that osteoclasts, which are important cellular mediators of skeletal homeostasis, are derived from hematopoietic precursors that also give rise to immune cells. In addition, numerous cytokines that were first shown to regulate immune cell function have also been demonstrated to regulate bone cells and influence skeletal health. Conversely, products of bone cells appear critical for the engraftment of marrow in bone, the normal development of the hematopoietic and immune systems and provide niche for long-term memory B and T cells.

In the past scientists involved in immune and bone cell investigations have rarely interacted in a significant way as these disciplines have developed independently and, for the most part, remain separate. The conference will bring together leading international scientists from both fields to interact so that new collaboration can develop and more rapid progress in understanding the relationships between these fields can be achieved. Short talks will be selected from abstracts from the international community. This conference will have a format to provide an environment of maximum interaction and interchange through lectures, posters, and open discussion.

This is the second edition of this proceedings. Contributors include leading names in the field of research, addressing mutiple topics, which were covered at the last Osteoimmunology conference.

A Key Regulator of Postnatal Skeletal Remodeling.- Ectodomain Shedding of Receptor Activator of NF-KB Ligand.- The Negative Role Of Ids In Osteoclastogenesis.- Functional Genetic and Genomic Analysis of Modeled Arthritis.- Dexamethsone Suppresses Bone Formation via the Osteoclast.- Immunologic Regulation Of Bone Development.- Pth Regulates The Hematopoietic Stem Cell Niche In Bone.- Regulation Of Hematopoietic Stem Cells In The Osteoblastic Niche.- The Chemokine Cxcl12 And Regulation Of Hsc And Lymphocyte Development In The Bone Marrow Niche.- Osteoclast Precursor Cells.- Interaction with estrogen receptors as treatment of arthritis and osteoporosis.- Novel Signaling Pathways And Therapeutic Targets In Osteoclasts.- The Enigmatic Function of TREM-2 in Osteoclastogenesis.- Role of cell-matrix interactions in osteoclast differentiation.- Positive and negative roles of IL-6, STAT3 and SOCS3 in inflammatory arthritis.- Control of Osteoclast activity and bone loss by IKK subunits: new targets for therapy.- Targeting Osteoporosis And Rheumatoid Arthritis By Active Vaccination Against Rankl.- RANKL Inhibition: From Mice to Men (and Women).

It has only recently been appreciated that the immune and skeletal systems have major interactions. It is now well documented that osteoclasts, which are important cellular mediators of skeletal homeostasis, are derived from hematopoietic precursors that also give rise to immune cells. In addition, numerous cytokines that were first shown to regulate immune cell function have also been demonstrated to regulate bone cells and influence skeletal health. Conversely, products of bone cells appear critical for the engraftment of marrow in bone, the normal development of the hematopoietic and immune systems and provide niche for long-term memory B and T cells.

In the past scientists involved in immune and bone cell investigations have rarely interacted in a significant way as these disciplines have developed independently and, for the most part, remain separate. The conference will bring together leading international scientists from both fields to interact so that new collaboration can develop and more rapid progress in understanding the relationships between these fields can be achieved. Short talks will be selected from abstracts from the international community. This conference will have a format to provide an environment of maximum interaction and interchange through lectures, posters, and open discussion.